George Xinarianos Selected Research

Diffuse Palmoplantar Keratoderma (Tylosis)

7/2006	Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer.
4/2006	Down-regulation of the cytoglobin gene, located on 17q25, in tylosis with oesophageal cancer (TOC): evidence for trans-allele repression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

George Xinarianos Research Topics

Disease

9	Neoplasms (Cancer) 08/2013 - 07/2003
8	Lung Neoplasms (Lung Cancer) 07/2017 - 11/2006
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2011 - 09/2002
2	Hypoxia (Hypoxemia) 07/2017 - 12/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2011 - 01/2011
2	Adenocarcinoma of Lung 12/2011 - 03/2011
2	Breast Neoplasms (Breast Cancer) 09/2008 - 06/2002
2	Diffuse Palmoplantar Keratoderma (Tylosis) 07/2006 - 04/2006
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2015
1	Fever (Fevers) 01/2015
1	Postpartum Hemorrhage 01/2015
1	Body Weight (Weight, Body) 07/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2013
1	Adenocarcinoma 12/2011
1	Carcinoma (Carcinomatosis) 03/2011
1	Kidney Neoplasms (Kidney Cancer) 10/2010
1	Colonic Neoplasms (Colon Cancer) 10/2010
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2010
1	Genomic Instability 01/2009
1	Microsatellite Instability 07/2003
1	Colorectal Neoplasms (Colorectal Cancer) 07/2003
1	Transitional Cell Carcinoma 07/2003

Drug/Important Bio-Agent (IBA)

4	Messenger RNA (mRNA)IBA 12/2011 - 02/2009
3	CytoglobinIBA 08/2013 - 04/2006
3	Proteins (Proteins, Gene)FDA Link 12/2011 - 09/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 06/2002
2	Oxygen (Dioxygen)IBA 07/2017 - 12/2011
2	CarcinogensIBA 04/2010 - 04/2008
2	Biomarkers (Surrogate Marker)IBA 02/2009 - 11/2005
1	Misoprostol (Cytotec)FDA LinkGeneric 01/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 01/2015
1	trichostatin A (A 300)IBA 08/2013
1	Ritonavir (Norvir)FDA Link 07/2013
1	Imatinib Mesylate (Gleevec)FDA Link 01/2013
1	MyoglobinIBA 12/2011
1	NeuroglobinIBA 12/2011
1	GlobinsIBA 12/2011
1	Small Interfering RNA (siRNA)IBA 03/2011
1	Protein Isoforms (Isoforms)IBA 01/2011
1	Immunoglobulins (Immunoglobulin)IBA 10/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2010
1	HLA-Bw4 antigenIBA 10/2010
1	KIR ReceptorsIBA 10/2010
1	LigandsIBA 10/2010
1	Endothelin-1 (Endothelin 1)IBA 02/2009
1	Endothelins (Endothelin)IBA 02/2009
1	Endothelin B ReceptorIBA 02/2009
1	Retroelements (Retrotransposon)IBA 01/2009
1	DNA Transposable Elements (Element, IS)IBA 01/2009
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 04/2008
1	N'-nitrosonornicotine (nitrosonornicotine)IBA 04/2008
1	CytosineIBA 11/2006
1	ChromatinIBA 11/2005

Therapy/Procedure

1	Therapeutics 01/2009